2019-11-25 Bayer submits application to EMA for use of rivaroxaban in children with venous thromboembolism
2019-11-19 Bayer expands collaboration with the World Health Organization to fight pork tapeworm infections as cause for epilepsy
2019-11-18 Phase III VICTORIA study with vericiguat in patients with worsening chronic heart failure meets primary endpoint
2019-11-14 Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
2019-10-30 Bayer: Encouraging business performance across all divisions – agreements signed to divest Currenta and Animal Health
